(Press-News.org) Research from Karolinska Institutet in Sweden shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common forms of blood cancer and is generally incurable.
"Recently developed drugs, like bortezomib, have increased the survival rate for people with this serious and complex disease," says study leader Theocharis Panaretakis, docent of experimental oncology. "Having said this, the heterogeneity of the disease progression, the treatment response and the development of resistance to administered drugs which leads to the relapse of nearly all patients, has compelled us to find new and better treatments."
Myeloma is only found in adults; it is uncommon before the age of 40, and most patients are over 60 years when diagnosed. The disease can lie dormant in the body for many years, but only becomes life-threatening and requires treatment once the patient has begun to exhibit symptoms. The myeloma cells are mainly located in the bone marrow, and since this is where blood cells are produced, their presence seriously disrupts regular blood production. Malignant cancer cells or tumours can also accumulate outside the bone marrow, hence the term "multiple".
A common effect of multiple myeloma is osteoporosis, and as a consequence patients develop intense back pain as their vertebrae become compressed as well as bone fractures. Other symptoms are anaemia, fatigue, renal failure and, often, a greater susceptibility to infection.
The current study, which is published in the scientific journal Cancer Research, was conducted on cell samples from humans and mice (cell lines). Almost all myleoma patients, seen at Karolinska University Hospital, were previously untreated.
The researchers show how sorafenib induces cell death in human myeloma cell lines in a laboratory environment by preventing a certain kind of protein-level activity, an effect that also was achieved when the myeloma cells had developed a resistance to bortezomib. They also tested sorafenib in live mice and found that the drug either prevented or delayed the course of the disease. All in all, the researchers maintain that their results support the use of sorafenib in combination with other drugs in the treatment of multiple myeloma.
Research groups from Uppsala University and Belgium were also involved in the study. The project was financed by the Swedish Cancer Society, the Swedish Research Council, the Cancer Society in Stockholm and the Åke Wiberg Foundation.
###Publication: 'Sorafenib has potent anti-tumor activity against multiple myeloma in vitro, ex vivo and in vivo, in the 5T33MM mouse model', Pedram Kharaziha, Hendrik De Raeve, Charlotte Fristedt, Qiao Li, Astrid Gruber, Per Johnsson, Georgia Kokaraki, Maria Panzar, Edward Laane, Anders Österborg, Boris Zhivotovsky, Helena Jernberg-Wiklund, Dan Grandér, Fredrik Celsing, Magnus Björkholm, Karin Vanderkerken, Theocharis Panaretakis, Cancer Research, online first 4 September 2012, doi: 10.1158/0008-5472.CAN-12-0658.
Read the abstract: http://goo.gl/RnJrG
For further information, please contact:
Theocharis Panaretakis, docent
Department of Oncology-Pathology, Karolinska Institutet
Tel: +46 (0)8 517 732 18 or +46 (0)70 628 06 34
Email: theoharis.panaretakis@ki.se
Website: http://goo.gl/nX3fb
Contact the Press Office and download a photo:
http://ki.se/pressroom
More on Karolinska Instituet - a medical university:
http://ki.se/English
Possible new therapy for the treatment of a common blood cancer
2012-09-05
ELSE PRESS RELEASES FROM THIS DATE:
Brainy beverage: Study reveals how green tea boosts brain cell production to aid memory
2012-09-05
It has long been believed that drinking green tea is good for the memory. Now researchers have discovered how the chemical properties of China's favorite drink affect the generation of brain cells, providing benefits for memory and spatial learning. The research is published in Molecular Nutrition & Food Research.
"Green tea is a popular beverage across the world," said Professor Yun Bai from the Third Military Medical University, Chongqing, China. "There has been plenty of scientific attention on its use in helping prevent cardiovascular diseases, but now there is emerging ...
Can videogaming benefit young people with autism spectrum disorder?
2012-09-05
New Rochelle, NY, September 5, 2012—According to the Centers for Disease Control and Prevention (CDC), 1 in 88 children in the U.S. has autism spectrum disorder (ASD), a broad group of neurodevelopmental disorders. Children and adolescents with ASD are typically fascinated by screen-based technology such as videogames and these can be used for educational and treatment purposes as described in an insightful Roundtable Discussion published in Games for Health Journal: Research Development, and Clinical Applications, a peer-reviewed publication from Mary Ann Liebert, Inc.. ...
Trout will become extinct in the Iberian Peninsula in less than 100 years
2012-09-05
Climate change, pollution, the extraction of water for irrigation and overfishing all threaten the survival of the common trout. This fish is very sensitive to changes in its environment and, according to the Spanish study, its habitat will have reduced by half by the year 2040 and will have completely disappeared from Iberian rivers by 2100, so its population will become extinct.
Global warming is threatening the existence of many fish species, especially those in the salmonid family, which are sensitive to temperature changes as they require clear and fresh water to ...
Infections in rheumatoid arthritis patients: Mayo Clinic study finds way to pinpoint risk
2012-09-05
ROCHESTER, Minn. -- Rheumatoid arthritis alone is painful and disabling, but it also puts patients at higher risk of death. The greater susceptibility to infections that accompanies the autoimmune disorder is one reason. Assessing the danger of infection a particular patient faces so it can be addressed can prove challenging for physicians. A Mayo Clinic study finds that a risk score can be developed to predict a patient's chances of having serious infections. The score uses information about how rheumatoid arthritis is affecting a patient, plus factors including age, corticosteroid ...
Epigenetic causes of prostate cancer
2012-09-05
This press release is available in German.
In about half of all prostate tumours, there are two genetic areas that are fused with one another. When this is not the case, the exact way cancer cells originate in prostate tumours was not clear until now. Scientists at the Max Planck Institute for Molecular Genetics in Berlin, in cooperation with a team of international researchers, were able to show that the genesis of this fusion-negative prostate cancer has epigenetic causes: methyl groups are distributed differently over the DNA in the cancer cells than in healthy cells. ...
Harnessing anticancer drugs for the future fight against influenza
2012-09-05
Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki, together with its national and international collaborators, developed a new cell screening method that can be used to identify potential anti-influenza drugs. The researchers were able to identify two novel compounds with anti-influenza activity, obatoclax and gemcitabine and prove the efficacy of a previously known drug saliphenylhalamide.
The study was recently accepted for publication in the Journal of Biological Chemistry and is now available online.
Influenza ...
DNA sequences need quality time too - guidelines for quality control published
2012-09-05
Like all sources of information, DNA sequences come in various degrees of quality and reliability. To identify, proof, and discard compromised molecular data has thus become a critical component of the scientific endeavor - one that everyone generating sequence data is assumed to carry out before using the sequences for research purposes.
"Many researchers find sequence quality control difficult, though", says Dr. Henrik Nilsson of the University of Gothenburg and the lead author of a new article on sequence reliability, published in the Open Access journal MycoKeys. ...
Archaeology team announces 'huge step forward' in King Richard III search
2012-09-05
Archaeologists from the University of Leicester who are leading the search for King Richard III have announced they have overcome the first significant hurdle of their investigation – and made a huge step forward in the search for the King by locating the church where he was buried.
The University of Leicester is leading the archaeological search for the burial place of King Richard III with Leicester City Council, in association with the Richard III Society.
In 1485 King Richard III was defeated at the battle of Bosworth. His body, stripped and despoiled, was brought ...
Study uncovers simple way of predicting severe pain following breast cancer surgery
2012-09-05
WOMEN having surgery for breast cancer are up to three times more likely to have severe pain in the first week after surgery if they suffer from other painful conditions, such as arthritis, low back pain and migraine, according to a Cancer Research UK study published today (Wednesday) in the British Journal of Cancer.
Of the women surveyed, 41 per cent reported moderate to severe pain at rest, and 50 per cent on movement, one week after their surgery. Most patients having breast cancer surgery are discharged home by this time.
Psychological state was also important, ...
When do we lie? When we're short on time and long on reasons
2012-09-05
Almost all of us have been tempted to lie at some point, whether about our GPA, our annual income, or our age. But what makes us actually do it?
In a study forthcoming in Psychological Science, a journal of the Association for Psychological Science, psychological scientists Shaul Shalvi of the University of Amsterdam and Ori Eldar and Yoella Bereby-Meyer of Ben Gurion University investigated what factors influence dishonest behavior.
Previous research shows that a person's first instinct is to serve his or her own self-interest. And research also shows that people are ...